| Titolo | Fase | Stato | Sede patologia | Strutture coinvolte | Dettaglio |
International Multicenter Real-World Registry for patients with metastatic renal cell carcinoma Meet-URO 33 study (REGAL study) |
NA |
in corso |
carcinoma renale metastatico |
- SC Oncologia Clinica Sperimentale Uro - Ginecologica |
|
ANGIOSARCOMA MAMMARIO: CARATTERISTICHE CLINICOPATOLOGICHE E POTENZIALE IMPATTO PROGNOSTICO DEI MARKERS IMMUNOTERAPICI. |
NA |
in corso |
Angiosarcoma mammario |
SC Anatomia Patologica e Citopatologia - |
|
TROPION-Breast05 A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer |
III |
in corso |
CARCINOMA MAMMARIO |
- SC Oncologia Clinica Sperimentale di Senologia |
|
REGISTRO INTERNAZIONALE PROSPETTICO SULLA RICOSTRUZIONE MAMMARIA PRE-PETTORALE |
NA |
in corso |
Tumore della mammella |
- SC Chirurgia Oncologica di Senologia |
|
AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 2 STUDY OF THE ATR INHIBITOR TUVUSERTIB IN COMBINATION WITH THE PARP INHIBITOR NIRAPARIB OR THE ATM INHIBITOR LARTESERTIB IN PARTICIPANTS WITH BRCA MUTANT AND/OR OMOLOGOUS RECOMBINATION DEFICIENCY HRD)‑POSITIVE EPITHELIAL OVARIAN CANCER THAT PROGRESSED ON PRIOR PARP INHIBITOR THERAPY |
II |
in corso |
CANCRO OVARICO |
- SC Oncologia Clinica Sperimentale Uro - Ginecologica |
